Mast Cell Inhibition Improves Pulmonary Vascular Remodeling in Pulmonary Hypertension-Reference-Cited by-同舟云学术

Mast Cell Inhibition Improves Pulmonary Vascular Remodeling in Pulmonary Hypertension

Published:2012-03 Issue:3 Volume:141 Page:651-660
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Bartelds Beatrijs,van Loon Rosa Laura E.,Mohaupt Saffloer,Wijnberg Hans,Dickinson Michael G.,Boersma Bibiche,Takens Janny,van Albada Mirjam,Berger Rolf M.F.

Publisher

Elsevier BV

Reference41 articles.

1. Possibilities and impossibilities in the evaluation of pulmonary vascular disease in congenital heart defects;Berger;Eur Heart J,2000

2. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era;Humbert;Circulation,2010

3. Biopsy Pathology of the Pulmonary Vasculature;Wagenvoort,1989

4. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure;Stenmark;Am J Physiol Lung Cell Mol Physiol,2009

5. Pathobiology of pulmonary hypertension;Rabinovitch;Annu Rev Pathol,2007

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Insights from Pathology to Clinic in Pulmonary Hypertension: Focus on Immune-inflammatory Response and Signaling;Inflammation;2025

2. Mast Cells Mediate Acute Inflammatory Responses After Glenoid Labral Tears and Can Be Inhibited With Cromolyn in a Rat Model;The American Journal of Sports Medicine;2024-10-06

3. Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management;International Journal of Molecular Sciences;2024-08-01

4. Mast Cells in Cardiac Remodeling: Focus on the Right Ventricle;Journal of Cardiovascular Development and Disease;2024-02-04

5. Molecular and immunological basis of pulmonary arterial hypertension and pulmonary veno-occlusive disease;Genomic and Molecular Cardiovascular Medicine;2024